 |  |  |
|  |
|
| |||||||||||||||||||||||||||||||
|
|
| | |||||||
|
| 1. | Title: Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications
Author(s): Wulff H, Kolski-Andreaco A, Sankaranarayanan A, et al. Source: CURRENT MEDICINAL CHEMISTRY Volume: 14 Issue: 13 Pages: 1437-1457 Published: 2007 |
| 2. | Title: K+ channel modulators for the treatment of neurological disorders and autoimmune diseases
Author(s): Wulff H, Zhorov BS Source: CHEMICAL REVIEWS Volume: 108 Issue: 5 Pages: 1744-1773 Published: MAY 2008 |
| 3. | Title: KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?
Author(s): Chou CC, Lunn CA, Murgolo NJ Source: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS Volume: 8 Issue: 2 Pages: 179-187 Published: MAR 2008 |
| 4. | Title: The Ca2+-activated K+ channel of intermediate conductance: A molecular target for novel treatments?
Author(s): Jensen BS, Strobaek D, Olesen SP, et al. Source: CURRENT DRUG TARGETS Volume: 2 Issue: 4 Pages: 401-422 Published: DEC 2001 |
| 5. | Title: Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice
Author(s): Reich EP, Cui L, Yang L, et al. Source: EUROPEAN JOURNAL OF IMMUNOLOGY Volume: 35 Issue: 4 Pages: 1027-1036 Published: APR 2005 |
| 6. | Title: The functional network of ion channels in T lymphocytes
Author(s): Cahalan MD, Chandy KG Source: IMMUNOLOGICAL REVIEWS Volume: 231 Pages: 59-87 Published: SEP 2009 |
| 7. | Title: Kv1.3 potassium channels as a therapeutic target in multiple sclerosis
Author(s): Rangaraju S, Chi V, Pennington MW, et al. Source: EXPERT OPINION ON THERAPEUTIC TARGETS Volume: 13 Issue: 8 Pages: 909-924 Published: AUG 2009 |
| 8. | Title: The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy
Author(s): Bradding P, Wulff H Source: BRITISH JOURNAL OF PHARMACOLOGY Volume: 157 Issue: 8 Pages: 1330-1339 Published: AUG 2009 |
| 9. | Title: Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain
Author(s): Pedarzani P, Stocker M Source: CELLULAR AND MOLECULAR LIFE SCIENCES Volume: 65 Issue: 20 Pages: 3196-3217 Published: OCT 2008 |
| 10. | Title: The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans
Author(s): Toyama K, Wulff H, Chandy KG, et al. Source: JOURNAL OF CLINICAL INVESTIGATION Volume: 118 Issue: 9 Pages: 3025-3037 Published: SEP 2008 |
|  |
